U.S. Food and Drug Administration Coronavirus (COVID-19) Update: January 26, 2021 | site |




(Information contained in U.S. Food and Drug Administration [FDA] press release dated: January 26, 2021)


The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:
  • The agency has updated its FDA COVID-19 Response At-A-Glance Summary, which provides a quick look at facts, figures, and highlights on the FDA's response efforts.
  • Testing updates:
    • As of today, 320 tests and sample collection devices are authorized by the FDA under emergency use authorizations (EUAs). These include 238 molecular tests and sample collection devices, 69 antibody tests, and 13 antigen tests. There are 33 molecular authorizations that can be used with home-collected samples. There is one molecular prescription at-home test, one antigen prescription at-home test, and one over-the-counter (OTC) at-home antigen test.